Lobbying

Laboratory Corporation of America's latest lobbying report covers Q2 2026, at $452K. The four quarters Q4 2025–Q3 2026 total $2M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Taxation/Internal Revenue Code.

Laboratory Corporation of America

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$2M
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Laboratory Corporation of America lobbying by quarter
Laboratory Corporation of America lobbying by quarter
QuarterAmountReports
Q4 2022$432K4
Q1 2023$1.5M4
Q2 2023$452K4
Q3 2023$442K4
Q4 2023$432K4
Q1 2024$992K4
Q2 2024$442K4
Q3 2024$452K4
Q4 2024$422K4
Q1 2025$1M4
Q2 2025$452K4
Q3 2025$442K4
Q4 2025$492K4
Q1 2026$1.1M4
Q2 2026$452K4
Q3 2026$00

By issue

  • Health issues$6.8M · 46 reports
  • Taxation$1.7M · 11 reports
  • Medicare and Medicaid$240K · 10 reports
  • Medical research and clinical labs$210K · 5 reports
  • Budget and appropriations$135K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES45 reports
  • SENATE45 reports
  • Centers For Medicare and Medicaid Services (CMS)5 reports
  • Health & Human Services, Dept of (HHS)5 reports
  • White House Office3 reports
  • Justice, Dept of (DOJ)2 reports
  • Substance Abuse & Mental Health Services Administration (SAMHSA)2 reports
  • Transportation, Dept of (DOT)2 reports
  • Centers For Disease Control & Prevention (CDC)1 reports
  • Executive Office of the President (EOP)1 reports
  • Health Resources & Services Administration (HRSA)1 reports
  • Indian Health Service1 reports
  • Natl Institutes of Health (NIH)1 reports
  • Occupational Safety & Health Administration (OSHA)1 reports
  • Office of the Vice President of the United States1 reports
  • Veterans Affairs, Dept of (VA)1 reports

Firms it paid

Firm
In-houseLaboratory Corporation of America Holdings$6.8M15 quarters
Kelley Drye & Warren$1.7M15 quarters
Akin Gump Strauss Hauer & Feld$900K15 quarters
Parker, Poe, Adams & Bernstein$180K15 quarters

Former officials lobbying for it

Former position
ANNA ABRAMDpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06Q1 2025
MIA HECKConfidential Asst. to Asst. Sec Pub. Affairs, ASPA, HHS (9/02 - 3/04); Dir. Special Proj., IOS, HHS (1/05 - 2/06); Snr Adv. to Administrator, CMS, HHS (10/17 - 1/18); Snr Adv., IEA, HHS (1/18 - 6/19); Dir. External Affairs, OASH, HSS (6/19-1/21)Q2 2024

Lobbying reports

Filed by
07/20for Q2Parker, Poe, Adams & Bernstein$12K
07/20for Q2Kelley Drye & Warren$110K
07/20for Q2Akin Gump Strauss Hauer & Feld$60K
07/14for Q2In-house$270K
04/20for Q1Parker, Poe, Adams & Bernstein$12K
04/20for Q1Kelley Drye & Warren$110K
04/20for Q1Akin Gump Strauss Hauer & Feld$60K
04/13for Q1In-house$890K
04/13for Q4 2025In-house$310K
02/05for Q4 2025Parker, Poe, Adams & Bernstein$12K
01/20for Q4 2025Kelley Drye & Warren$110K
01/20for Q4 2025Akin Gump Strauss Hauer & Feld$60K
01/13for Q4 2025In-house$250K
01/13for Q3 2025In-house$260K
25/11/06for Q3 2025Parker, Poe, Adams & Bernstein$12K
25/10/20for Q3 2025Kelley Drye & Warren$110K
25/10/20for Q3 2025Akin Gump Strauss Hauer & Feld$60K
25/10/01for Q3 2025In-house$270K
25/08/05for Q2 2025Parker, Poe, Adams & Bernstein$12K
25/07/21for Q2 2025Akin Gump Strauss Hauer & Feld$60K